ArticleVaccines2025

Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab.

Jelena Drulovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.